Influence of Creatinine Clearance on Survival Parameters in Small Cell Lung Cancer Treated with Cisplatin-Based Chemotherapy Regimen

被引：0
|
作者：
Gozel, Sedat [1 ]
Sumbul, Ahmet [1 ]
Sedef, Ali Murat [1 ]
Besen, Ayberk [1 ]
Mertsoylu, Huseyin [1 ]
Batmaci, Celal [2 ]
Kose, Fatih [3 ]
机构：
[1] Baskent Univ, Adana, Turkey
[2] Hakkari Devlet Hastanesi, Hakkari, Turkey
[3] Baskent Univ, Med Oncol, Adana, Turkey
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
creatinine clearance; small cell lung cancer; survival;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.07-010
引用
收藏
页码：S701 / S702
页数：2
相关论文
共 50 条
  • [1] Aortic thrombosis resolved with enoxaparin in a patient treated with cisplatin-based regimen for small cell lung cancer
    Chin, Sang Ouk
    Lee, Jae Jin
    Hwang, Yeon Hee
    Han, Jae Joon
    Maeng, Chi Hoong
    Baek, Sun Kyung
    Choi, Cheong Woong
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 91 (05) : 892 - 896
  • [2] Aortic thrombosis resolved with enoxaparin in a patient treated with cisplatin-based regimen for small cell lung cancer
    Sang Ouk Chin
    Jae Jin Lee
    Yeon Hee Hwang
    Jae Joon Han
    Chi Hoong Maeng
    Sun Kyung Baek
    Cheong Woong Choi
    International Journal of Hematology, 2010, 91 : 892 - 896
  • [3] Serial-measured versus estimated creatinine clearance in patients with non-small cell lung cancer receiving cisplatin-based chemotherapy
    Chang, GC
    Yang, TY
    Shih, CM
    Lin, LY
    Lee, HS
    Chiang, CD
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2003, 102 (04) : 257 - 261
  • [4] Phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancer
    Sculier, J. P.
    Lafitte, J. J.
    Lecomte, J.
    Alexopoulos, C. G.
    Van Cutsem, O.
    Giner, V.
    Efremidis, A.
    Berchier, M. C.
    Collon, T.
    Meert, A. P.
    Scherpereel, A.
    Ninane, V.
    Paesmans, M.
    Berghmans, T.
    ANNALS OF ONCOLOGY, 2007, 18 (06) : 1037 - 1042
  • [5] Survival of patients with advanced urothelial cancer treated with cisplatin-based chemotherapy
    Fossa, SD
    Sternberg, C
    Scher, HI
    Theodore, CH
    Mead, B
    Dearnaley, D
    Roberts, JT
    Skovlund, E
    BRITISH JOURNAL OF CANCER, 1996, 74 (10) : 1655 - 1659
  • [6] CISPLATIN-BASED CHEMOTHERAPY IN ELDERLY PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Li, Jian
    Li, Xiao-Qin
    Du, Young-Jie
    Ge, Li-Ping
    Dai, Chun-Hua
    Chen, Ping
    INTERNATIONAL JOURNAL OF GERONTOLOGY, 2010, 4 (01) : 28 - 36
  • [7] Formulas calculating creatinine clearance are inadequate for determining eligibility for cisplatin-based chemotherapy in bladder cancer
    Raj, Ganesh V.
    Iasonos, Alexia
    Herr, Harry
    Donat, Sherri Machele
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (19) : 3095 - 3100
  • [8] Nedaplatin- versus cisplatin-based chemotherapy in the survival time of patients with non-small cell lung cancer
    Shan, Jinlu
    Xiong, Yanli
    Wang, Dong
    Xu, Mingfang
    Yang, Yi
    Gong, Kan
    Yang, Zhenzhou
    Wang, Ge
    Yang, Xueqin
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (03) : 543 - 549
  • [9] Influence of tumor response on the survival of patients with extensive-stage small-cell lung cancer treated with the etoposide plus cisplatin chemotherapy regimen
    Guojing Zhang
    Yongye Liu
    Chao Lin
    Jianfei Guo
    Long Xu
    Junling Liu
    Ying Piao
    Guanzhong Zhang
    Yuhui Liu
    Yaling Han
    Xiaodong Xie
    OncologyandTranslationalMedicine, 2015, 1 (02) : 65 - 68
  • [10] Thrombocytosis and immunohistochemical expression of connexin 43 at diagnosis predict survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy
    Gangjun Du
    Yingming Yang
    Yaping Zhang
    Ting Sun
    Weijie Liu
    Yingying Wang
    Jiahuan Li
    Houyun Zhang
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 893 - 904
12345